JP2004529890A - 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系 - Google Patents

活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系 Download PDF

Info

Publication number
JP2004529890A
JP2004529890A JP2002569118A JP2002569118A JP2004529890A JP 2004529890 A JP2004529890 A JP 2004529890A JP 2002569118 A JP2002569118 A JP 2002569118A JP 2002569118 A JP2002569118 A JP 2002569118A JP 2004529890 A JP2004529890 A JP 2004529890A
Authority
JP
Japan
Prior art keywords
nicotine
skin
tts
permeable
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002569118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529890A5 (https=
Inventor
シュテファン・ブラハト
ザビーネ・ヴァルヌス
Original Assignee
エルテーエス ローマン テラピー−ジステーメ アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エルテーエス ローマン テラピー−ジステーメ アーゲー filed Critical エルテーエス ローマン テラピー−ジステーメ アーゲー
Publication of JP2004529890A publication Critical patent/JP2004529890A/ja
Publication of JP2004529890A5 publication Critical patent/JP2004529890A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2002569118A 2001-03-03 2002-02-19 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系 Pending JP2004529890A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10110391A DE10110391A1 (de) 2001-03-03 2001-03-03 Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
PCT/EP2002/001728 WO2002069940A2 (de) 2001-03-03 2002-02-19 Hochflexibles transdermales therapeutisches system mit nikotin als wirkstoff

Publications (2)

Publication Number Publication Date
JP2004529890A true JP2004529890A (ja) 2004-09-30
JP2004529890A5 JP2004529890A5 (https=) 2006-08-03

Family

ID=7676278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002569118A Pending JP2004529890A (ja) 2001-03-03 2002-02-19 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系

Country Status (21)

Country Link
US (1) US8226974B2 (https=)
EP (1) EP1372619B1 (https=)
JP (1) JP2004529890A (https=)
KR (1) KR100873257B1 (https=)
CN (1) CN1330305C (https=)
AR (1) AR035688A1 (https=)
AU (1) AU2002308289B2 (https=)
BR (1) BR0207738A (https=)
CA (1) CA2440012C (https=)
CZ (1) CZ20032379A3 (https=)
DE (1) DE10110391A1 (https=)
ES (1) ES2386886T3 (https=)
HU (1) HUP0303311A3 (https=)
IL (2) IL157692A0 (https=)
MX (1) MXPA03007903A (https=)
NZ (1) NZ527824A (https=)
PL (1) PL205582B1 (https=)
RU (1) RU2302856C2 (https=)
TW (1) TWI264312B (https=)
WO (1) WO2002069940A2 (https=)
ZA (1) ZA200306194B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031427A (ja) * 2005-06-21 2007-02-08 Nitto Denko Corp ニコチン含有経皮吸収製剤

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20321052U1 (de) * 2002-05-28 2005-09-22 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend Fentanylum
BRPI0412752B8 (pt) * 2003-07-24 2021-05-25 Glaxosmithkline Llc composição de filme de dissolução oral
RU2263503C1 (ru) * 2004-04-23 2005-11-10 Каш Тенгиз Способ получения препарата и препарат для трансдермального введения никотина
ITMI20041628A1 (it) 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
DE102005010255A1 (de) † 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
EP1774964B1 (en) * 2005-10-13 2014-08-06 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
JP2009519246A (ja) * 2005-12-08 2009-05-14 フェルティン ファルマ 経皮タバコアルカロイドパッチ
WO2007065428A1 (en) * 2005-12-08 2007-06-14 Fertin Pharma Low flexural strength transdermal tobacco alkaloid patch
DE102006026060B4 (de) * 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
WO2008145119A1 (en) * 2007-05-31 2008-12-04 Fertin Pharma A/S Transdermal tobacco alkaloid reservoir patch
KR101883410B1 (ko) * 2011-04-22 2018-07-30 아이큐어 주식회사 경피 흡수 제제 및 그 제조방법
FR2987561B1 (fr) * 2012-03-02 2014-04-11 Pf Medicament Dispositif transdermique comprenant des micro-particules poreuses
CA2981397C (en) * 2015-04-08 2023-04-04 Lts Lohmann Therapie-Systeme Ag Electrically heatable plaster
EP3346998B1 (en) * 2015-08-17 2025-04-16 Sidmak Laboratories (India) PVT. Ltd. Topical film delivery system
DE102018220589A1 (de) * 2018-11-29 2020-06-04 Lts Lohmann Therapie-Systeme Ag Transdermales System mit Überpflaster und Ringsystem
DE102020112143B4 (de) 2020-05-05 2022-03-17 Lts Lohmann Therapie-Systeme Ag Nicotin - Corona
CA3203975A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
CA3216359A1 (en) 2021-04-07 2022-10-13 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
AU2024353375A1 (en) 2023-09-29 2026-04-09 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278018A (en) * 1979-11-16 1981-07-14 Ncr Canada Ltd. - Ncr Canada Ltee Printing means
JPS61251619A (ja) 1985-04-30 1986-11-08 Nitto Electric Ind Co Ltd ニコチン含有テ−プ製剤
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
DE3727232A1 (de) * 1987-08-14 1989-02-23 Lohmann Therapie Syst Lts Verfahren zur herstellung einer darreichungs- und/oder dosierungsform fuer arzneimittelwirkstoffe
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5364630A (en) 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
DE3827561C1 (https=) 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE3843238C1 (https=) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3908432A1 (de) 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
EP0484543B1 (en) 1990-04-24 1995-12-13 Teijin Limited Plaster
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
CA2142871A1 (en) 1992-08-25 1994-03-03 Jesus Miranda Printed transdermal drug delivery device
WO1995001766A1 (en) 1993-07-09 1995-01-19 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JP3021661B2 (ja) * 1994-03-07 2000-03-15 セラテック・インコーポレーテッド 薬剤含有接着複合体の経皮放出デバイス
DE4416927C1 (de) 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
KR0155193B1 (ko) * 1994-10-04 1998-10-15 신재인 중하중 취급 및 미끄럼 방지용 전방향 바퀴
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19826592A1 (de) * 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
NZ525878A (en) 1998-12-07 2004-12-24 Elan Pharma Int Ltd A method of treating nicotine dependance with mecamylamine
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031427A (ja) * 2005-06-21 2007-02-08 Nitto Denko Corp ニコチン含有経皮吸収製剤

Also Published As

Publication number Publication date
WO2002069940A3 (de) 2003-01-09
BR0207738A (pt) 2004-03-09
NZ527824A (en) 2005-05-27
CZ20032379A3 (cs) 2004-02-18
WO2002069940A2 (de) 2002-09-12
CN1330305C (zh) 2007-08-08
RU2003129636A (ru) 2005-01-27
US8226974B2 (en) 2012-07-24
DE10110391A1 (de) 2002-09-26
RU2302856C2 (ru) 2007-07-20
KR20030082952A (ko) 2003-10-23
CA2440012A1 (en) 2002-09-12
ZA200306194B (en) 2004-02-17
IL157692A0 (en) 2004-03-28
TWI264312B (en) 2006-10-21
EP1372619B1 (de) 2012-05-30
AU2002308289B2 (en) 2006-07-20
HUP0303311A3 (en) 2010-04-28
KR100873257B1 (ko) 2008-12-11
ES2386886T3 (es) 2012-09-04
MXPA03007903A (es) 2003-12-04
CA2440012C (en) 2011-05-31
PL363697A1 (en) 2004-11-29
EP1372619A2 (de) 2004-01-02
HUP0303311A2 (hu) 2004-01-28
CN1494421A (zh) 2004-05-05
IL157692A (en) 2012-06-28
PL205582B1 (pl) 2010-05-31
AR035688A1 (es) 2004-06-23
US20040096490A1 (en) 2004-05-20

Similar Documents

Publication Publication Date Title
JP2004529890A (ja) 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系
KR20130042520A (ko) 니코틴 경피 전달 시스템
JP2004507489A (ja) ベンラファキシンを放出するための経皮治療システム
NO329042B1 (no) Transdermale, terapeutiske systemer (TTS) inneholdende pergolid og fremgangsmate for fremstilling derav.
KR20010036685A (ko) 펜타닐을 함유하는 매트릭스형 경피투여제
JP2638635B2 (ja) 経皮吸収製剤
KR100581393B1 (ko) 개별층으로 구성된 적층물의 제조 방법
JPH0667835B2 (ja) 医薬組成物
WO2006090782A1 (ja) 含水系外用貼付剤用組成物及びこの組成物を用いた貼付剤
CN103338771A (zh) 贴剂
JPH07116032B2 (ja) ニトログリセリン貼付剤
KR100473677B1 (ko) 물리적 특성이 향상된 폴리아크릴레이트 매트릭스를 구비한 경피 또는 국소 플래스터 시스템
JPH07116023B2 (ja) ポリウレタンフィルムを支持体とする貼付剤
JP2009173679A (ja) 部分的ドーパミン−ｄ２作用薬の投与用の経皮治療吸収システム
JP2002537244A (ja) デオキシペガニン経皮治療系
JP5818709B2 (ja) 貼付製剤
TW202011993A (zh) 含水系貼附劑
JP2020518553A5 (https=)
JPH01233213A (ja) 貼付剤
JPH01233212A (ja) 貼付剤
JP2000501718A (ja) 皮膚塗布用の表面安定化された調合薬
JPH07145061A (ja) 経皮吸収製剤
JP3098095B2 (ja) 透湿性支持体を用いた貼付剤
JP2002275056A (ja) 貼付材とその製造方法
JP2003505411A (ja) カルシウムアンタゴニストを投与するための経皮治療系

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081226

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090324